by Paul Fassa
Health Impact News
As has been reported numerous times here at Health Impact News for the past 6 years or so, the pharmaceutical industry has been desperate to find an Alzheimer’s drug to market to an aging baby boomer population with ever increasing numbers of Alzheimer’s Disease cases.
And yet, billions of dollars have been invested in potential drugs only to see these drugs never make it out of the trial phase and come to market, because they do not significantly help Alzheimer’s patients.
Biogen and their partner Eisai are the latest pharmaceutical companies to throw in the towel regarding their Alzheimer’s drug aducanumab, which has failed to make it out of phase 3 trials.
Many drug researchers have now abandoned the theory of amyloid plaque accumulation in the brain as the causative factor of Alzheimer’s. Could aducanumab’s failure be the last nail in the coffin for this theory, as natural approaches to Alzheimer’s such as coconut oil and the ketogenic diet see more positive results?
Biogen Endures the Latest Pharmaceutical Failure with Solving Alzheimer’s Disease
An independent risk assessment during Biogen’s early phase 3 trials signaled the end of their efforts to develop a “blockbuster drug” based on aducanumab for Alzheimer’s.
Aducanumab is a solution of synthetically-derived antibodies based on human cells that have been specifically arranged to attack amyloid beta (AB) antigens. Amyloid beta plaques are considered the stuff of Alzheimer’s disease. Bioengineering antibodies is one aspect of immunotherapy.
Phase 3 trials are near the end of clinical trials involving humans with the largest numbers, 300 to 3,000 humans with the disease the drug is intended for. Before clinical trials begin, there must be satisfactory in vitro and in vivo (lab animal) results that suggest possible medical merits.
Phase 3 trials are considered pivotal towards the final marketing license granted by the FDA upon receiving two apparently positive clinical trial reports from the pharmaceutical company. There’s a phase 4, which is the post-market gathering of adverse side effects. (Source)
Cambridge, Massachusetts-based Biogen and its partner for these trials, Tokyo, Japan-based Eisai wound up sending 3,200 early-phase Alzheimer’s patients to their international homes with a “sorry” and “thanks.“
The independent risk assessment that predicted there would be no successful efficacious outcome on any significant level was convincing enough to drop the risk of losing more money and failing their stockholders.
The expected outcome was increased memory and mental acuity of most patients with minimal severe side effects for their phase 3 participants with early-stage Alzheimer’s disease.
If there were no adverse events or safety issues among the participants, as Biogen officially stated, then they were not getting enough restored memories, cognitive improvement, and improved dispositions to continue throwing money at the project.
If the earlier in vitro tests (lab culture experiments) had shown strong evidence of getting rid of amyloid beta plaque, why wasn’t it working to at least marginally improve enough human trial participants to continue the phase 3 trials?
University College of London’s John Hardy’s answer was:
This tells us that removal of amyloid in people with the disease is too late. Amyloid is a disease trigger. Once the neurodegenerative disease process is up and running, it is up and running. (Source)
David Holtzman, Washington University, St. Louis, added:
Even though this trial was in the early symptomatic phase of AD [Alzheimer’s disease], it is still in the phase when Aβ [amyoid beta] is no longer likely to be the driving process but where *tau and inflammation probably are. (Source)
Ron Petersen, Mayo Clinic, Rochester, Minnesota wrote regarding this recent failure to medically solve mainstream medicine’s AD riddle:
I think this solidifies the opinion that amyloid-targeted therapies do not have a clinical effect at the symptomatic stages of the disease process.
We clearly need other targets, and *tau is the leading candidate for now. (Source)
*Tau refers to the protein in brain cells that normally facilitates brain cell communication. It’s hypothesized that damaged or distorted tau proteins in brain cells may be the cause of Alzheimer’s disease that leads to the formation of amyloid beta plaque. (Source)
These three medical academics seem to be saying it’s possible all the pharmaceutical whizzes so far have been targeting the end result of Alzheimer’s disease instead of the potential source.
Maybe that’s why, prior to Biogen-Eisai’s failure, Eli Lilly’s AD (Alzheimer’s disease) drug failed during phase 3 trials. Other failures with developing a marketable AD drug include Johnson & Johnson, Pfizer, and Roche.
Thus far, the pharmaceutical industry has struck out each time at bat against AD. (Source)
Natural Options That Have Demonstrated Dramatic Improvements for AD Symptoms
Virgin Coconut Oil
An easier, less expensive, and more accessible alternative natural option for Alzheimer’s and other associated neurological disorders would be coconut oil.
Health experts and medical practitioners not under Big Pharma’s thumb have realized that Alzheimer’s disease and other neurological disorders are symptoms of type 2 diabetes of the brain.
Insulin resistance inhibits glucose from entering into cells for energy. It is the hallmark of diabetes 2.
Because of cellular insulin resistance, glucose is not making it into brain cells to energize them. Insulin is needed to carry glucose into cells for the energy required for proper metabolism. Some are calling this insulin resistance in the brain diabetes type 3.
But medium chain fatty acids or triglycerides (MCTs) provide ketones that are energy sources not dependent on insulin to carry them into brain cells. MCTs are not stored as fatty tissue triglycerides for future energy use.
The liver processes MCTs to produce ketones that are available for immediate energy use in brain cells without the need for insulin. That’s why so many have turned to virgin coconut oil to reduce and even reverse symptoms of Alzheimer’s, Parkinson’s disease, and other neurological disorders.
Not only are the results without adverse side effects, coconut oil offers other health benefits.
Depending on the severity of one’s neurological disorder, two to four tablespoons daily is usually sufficient for improving Alzheimer’s and Parkinson’s conditions as well as performing as a natural antibiotic, anti-fungal, and antiviral agent.
Using cannabis for Alzheimer’s or Parkinson’s disease and other related brain and nervous system disorders usually requires full spectrum cannabis with THC.
It has even been laboratory tested for what it can do for Alzheimer’s disease by the Salk Institute and the University of California, both in La Jolla, California.
Their findings were published in 2016 as Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids with the following conclusion:
Cannabinoids such as tetrahydrocannabinol [THC] stimulate the removal of intraneuronal Aβ, block the inflammatory response, and are protective. Altogether these data show that there is a complex and likely autocatalytic inflammatory response within nerve cells caused by the accumulation of intracellular Aβ, and that this early form of proteotoxicity can be blocked by the activation of cannabinoid receptors. (Study text)
This means that using cannabis with THC for any reason prevents amyloid beta formations and brain cell inflammation significantly, greatly reducing the risk of Alzheimer’s or other neurodegenerative diseases by eliminating the root cause before any symptoms arise, or stated simply, nipping it in the bud.
Study: Cannabis More Effective Than Pharmaceutical Drugs for Age-Related Neurodegenerative Diseases Like Alzheimer’s
Cannabis has opened up dramatically for medical use in over half of America’s states. But not all states have medical cannabis arrangements, and some of those that do may not allow full spectrum cannabis with THC for Alzheimer’s or Parkinson’s disease.
A cannabis doctor or cannabis dispensary consultant can be helpful with advising what condition other than Alzheimer’s or Parkinson’s disease a patient can use that’s allowable under his or her state’s guidelines.
This cannabis medical allowances state by state guide might be helpful.
Comment on this article at HealthImpactNews.com.
3 large organic potatoes with skin, thinly sliced
6 tablespoons of organic virgin coconut oil
sea salt for taste
Place a large, flat skillet on stove-top and heat on medium-high for a minute. Drop coconut oil onto skillet and let it melt. Arrange potato slices on top of the oil in a single layer and sprinkle them with salt. Cook until brown (about 10 minutes; longer depending on the thickness of the slices), then flip.
Cook another 10 minutes. Serve immediately. Makes 3 servings with two tablespoons of coconut oil per serving.
You can also add chopped onion, bell pepper,and/or diced garlic for variation. Or try using your favorite organic seasoning salt.
This recipe is adapted from Swanson Health Product’s Healthy Recipes found at: http://www.swansonvitamins.com/health-library/recipes/coconut-fried-potatoes.html
This recipe is especially good if you are on a coconut oil diet! If you want to learn more about how to lose weight with coconut oil, check out my website at http://coconut-oil-diet.com.
It’s a new month and July is all about the chicken wings! And with 4th of July only a couple of days away, what better way to prep for an awesome outdoor barbecue? Whether you like your wings on the grill, or in an air fryer, it is your day to celebrate. Did I mention I researched some Keto options too? We’ve got chicken wings for days!
This recipe is Keto-friendly and delicious!
2 lbs. of chicken wings (drumettes and flats)
½ of Parmesan Cheese (grated)
1 teaspoon of paprika
1 teaspoon of Herbes de Provence
Salt (to taste)
Pepper (to taste)
Kelapo Ghee Cooking Spray
Begin by preheating the air fryer to 350 degrees and spray the basket with the Kelapo Ghee Cooking Spray. Take the wings out of the freezer and once they’ve thawed completely, dry them with paper towels. In a small bowl, add the parmesan cheese, paprika, herbes de provence and salt and mix it together. Then coat the wings with the parmesan mic and place them in the air fryer. Cook the chicken wings for 15 to 18 minutes. Make sure not to overstuff the air fryer because the chicken wings won’t cook correctly. Garnish with more parmesan cheese on top once the wings are ready!
3 lbs of chicken wings
1 cup of flour
2 teaspoons of salt
1 teaspoon of pepper
1 ½ tablespoon of lemon pepper seasoning
¼ cup of Kelapo Ghee (melted)
1 tablespoon of parsley (chopped)
Oil (for frying)
In a large bowl, add the flour and season with the salt and pepper then stir everything together. If you want to add a bit more salt and pepper, be my guest! Toss the chicken wings in the bowl of flour and coat them completely. Fill a large pot with 4 inches of oil and set on high. Cook the chicken wings in batches and fry for about 15 minutes each, or until they turn golden brown. In a separate bowl add the melted Kelapo Ghee and lemon pepper seasoning. Drizzle over the cooked chicken wings and toss again! If you want a bit more flavor you can also squeeze half a lemon over the wings.
Peace, love and Kelapo
Study: Coconut Oil a Healthy Saturated Fat – But the FDA Prohibits the use of “Healthy” in Describing Coconut Oil
by Brian Shilhavy
Editor, Health Impact News
Recently we covered a study published in the journal Clinical Nutrition which compared peanut oil consumption with coconut oil consumption among healthy men in India, where those who consumed coconut oil had better health outcomes in terms of heart disease and diabetes. (See: Coconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.)
A researcher at The University of Edinburgh Medical School wrote a Letter to the Editor of Clinical Nutrition commenting on this study, criticizing current government nutritional guidelines regarding saturated dietary fat restrictions.
The cross-over study by Korrapati et al. detailed the potential cardioprotective effect of coconut oil, and I would like to thank the authors for their insight. Whilst the sample size was small, it was well-designed to investigate its primary end-points.
This study is particularly topical as, despite removal of the maximum dietary fat intake restriction from guidelines, a major resistance against saturated fats remains.
Setting aside the issue of whether or not saturated fats should be restricted at all, given the abundance of contrary evidence in the medical literature, the Edinburgh Medical School researcher reported that such guidelines do not distinguish between different types of saturated fats. Saturated fats can be found in animal products, such as butter, as well as plant sources, such as coconuts and date palms.
The rise in high density lipoprotein cholesterol (HDL-c) with coconut oil consumption is certainly a compelling finding. Results from a recent and larger-scale randomised trial by Khaw et al. corroborate this, but, interestingly, a similar HDL-c elevation was not seen with butter intake, which is also largely composed of saturated fatty acids (SFAs). Indeed, accruing evidence suggests that the saturated versus unsaturated distinction of fats is likely an oversimplification.
Korrapati et al. should, therefore, be commended on their focus on the biological properties of coconut oil, particularly the medium chain triglyceride (MCT) dominated fatty acid profile, which may confer atheroprotective effects.
Of note, a recent UK/Danish cohort study elicited that chain length is a major determinant of SFA-associated myocardial infarction risk, with no delineable, or even an inverse, relationship existing with short-tomedium chain SFA consumption.
The researcher also noted the inherent problems with most government nutritional guidelines to replace saturated fats with polyunsaturated fats that are supposed to be more “heart healthy,” when polyunsaturated fats are prone to lipid peroxidation which make them toxic, and are linked to inflammatory causes.
The promotion of polyunsaturated oils (mostly corn and soybean oils in western countries, but sometimes peanut oil in Asian countries like this study) in the modern day diet also leads to an Omega 6 to Omega 3 ratio imbalance.
I note that the detrimental impacts of peanut oil consumption were comparatively overlooked in the analysis; it would have been interesting to explore the authors’ interpretation of this data.
The unfavourable lipid profile, with elevation of low-density lipoprotein cholesterol (LDL-c), is an especially salient finding given the long-standing recommendations to substitute polyunsaturated fatty acids (PUFAs) in place of SFAs.
It is difficult to discern from the methodology whether the additional 35 g of coconut/peanut oil daily was provided in a cold formulation, or whether it was heated for meal preparation.
With a significantly greater PUFA content than coconut oil, peanut oil is more susceptible to lipid peroxidation during cooking; numerous studies have demonstrated a deranged metabolic profile, including elevated inflammatory markers and LDL-c, with hot vegetable oil intake , and, thus, clarification on this issue would be greatly appreciated.
Furthermore, whilst Korrapati et al. outline the 15-fold greater concentration of linoleic acid in peanut oil versus coconut oil, I wonder if this could have been further developed.
Linoleic acid represents the most abundant omega-6 fatty acid, and whilst no consensus has been reached regarding its contribution to cardiovascular disease, omega-3/omega-6 imbalance is becoming an increasingly contentious issue. (Source. Subscription or payment needed to view full article.)
USDA Dietary Advice on Saturated Fats Based on Faulty or Corrupt Research
The “lipid theory” of heart disease, the theory that blames saturated fat and cholesterol for causing heart disease, is widely believed to be linked to a researcher in the late 1950s and early 1960s by the name of Ancel Keys from the University of Minnesota.
His original study has been shown to be false, with selective bias being used to only select certain populations that fit his theory.
Journalist Paul John Scott, writing for the Star Tribune in 2011, admitted that Keys’ work was not widely accepted by scientists at the time, and now is considered “junk science.”
We told the world that heart disease is caused by elevated cholesterol and that reducing saturated fat in the diet reduces this risk. That led the country to embrace the lowering of cholesterol with medications. All of those assumptions have proven themselves to be either overstated, oversimplified or wrong, and that has led us astray. Would it be too much for the leading cardiologists in our community to admit as much?
“It was also nearly 60 years ago,” as Dr. Daniel J. Garry extolled on these pages (“Treating heart disease at the U: A story of steady innovations,” April 14), “that University of Minnesota scientists — Dr. Ancel Keys along with Drs. Francisco Grande and Joseph Anderson — defined the relationship between dietary fat and serum cholesterol, which linked cholesterol to heart disease.”
Garry went on to praise the creation of cholesterol-lowering drugs that stemmed from Keys’ work. Keys constructed his hypothesis after studying the diets and heart disease in countries across the globe. But his research left out nations with data that did not match the hypothesis, and even within the data he published, populations existed in which diet and heart disease were wildly out of synch with his model.
By 1970, an English researcher named John Yudkin would argue that sugar in the diet was the cause of heart disease in wealthy nations, but Keys, sensing that his theory was suddenly vulnerable to reconsideration, aggressively led the charge to have that research discredited. (Source.)
Nevertheless, this faulty research was used during the 1970s in a Congressional hearing to decide USDA nutritional advice in, and the infamous “McGovern Report” on nutrition resulted in condemning saturated fats and blaming them for causing heart disease, even over the objections of many scientists who did not believe Keys’ research.
This YouTube clip contains actual film footage by CBS news regarding the McGovern report in 1977, and how scientists cautioned the politicians at that time that the science did NOT support the conclusion that saturated fats and cholesterol caused heart disease.
In 2017, a group of researchers with the Philip R. Lee Institute for Health Policy Studies at the University of California at San Francisco (UCSF), reviewed historical scientific literature funded by the Sugar Research Foundation since the 1960s, which gives us a great perspective on how the war on saturated fats became public policy.
These researchers at UCSF, Cristin E. Kearns, DDS, MBA; Laura A. Schmidt, PhD, MSW, MPH; and Stanton A. Glantz, PhD, revealed how the Sugar Research Foundation (SRF) influenced Harvard medical researchers financially and otherwise to report open-ended inconclusive research that omitted a lot of conclusive negative health data.
Their first article was published in the Journal of the American Medical Association (JAMA Internal Medicine) in 2016.
The title of the study is Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents.
The New York Times, which has given some press to exposing the saturated fat myth for over ten years now, led the mainstream media outlets that covered the UCSF study:
Here are some excerpts:
The sugar industry paid scientists in the 1960s to play down the link between sugar and heart disease and promote saturated fat as the culprit instead, newly released historical documents show.
The internal sugar industry documents, recently discovered by a researcher at the University of California, San Francisco, and published Monday in JAMA Internal Medicine, suggest that five decades of research into the role of nutrition and heart disease, including many of today’s dietary recommendations, may have been largely shaped by the sugar industry.
“They were able to derail the discussion about sugar for decades,” said Stanton Glantz, a professor of medicine at U.C.S.F. and an author of the JAMA Internal Medicine paper.
The documents show that a trade group called the Sugar Research Foundation, known today as the Sugar Association, paid three Harvard scientists the equivalent of about $50,000 in today’s dollars to publish a 1967 review of research on sugar, fat and heart disease. The studies used in the review were handpicked by the sugar group, and the article, which was published in the prestigious New England Journal of Medicine, minimized the link between sugar and heart health and cast aspersions on the role of saturated fat.
Even though the influence-peddling revealed in the documents dates back nearly 50 years, more recent reports show that the food industry has continued to influence nutrition science.
NPR was another news source that covered the UCSF study in 2016:
The UCSF researchers disclosed how a top executive, John Hickson, vice-president of the SRF at the time took on the task of finding a way to discredit the increasing studies demonstrating sugar’s role in creating bad heart health.
Interestingly, a few years later in the early 1970s, Hickson became part of the tobacco industry’s PR machinery with the Cigar Research Council.
“In 1972, an internal tobacco industry memo on Mr. Hickson noted that he had a reputation for manipulating science to achieve his goals,” and “ …[he is] a supreme scientific politician who had been successful in condemning cyclamates [earlier artificial sweeteners], on behalf of the Sugar Research Council, on somewhat shaky evidence.” (Source)
Hickson had come up the idea of funding their own research which would enable them to legitimately and officially discredit all the anti-health sugar conclusions.
The operational key for this scheme was in Harvard, where “one of the researchers was the chairman of Harvard’s Public Health Nutrition Department — and an ad hoc member of SRF’s board.” (Source)
Their review was published in a 1967 issue of the New England Journal of Medicine.
The fact that it was published in such a prestigious journal as a scientific literature review was enough to establish legitimacy, at least enough to confuse, if not convince, with their inconclusive commentaries of “further studies needed.”
The review also maintained the now debunked lipid theory of heart disease by encouraging a low fat diet, which led to the McGovern Report.
Public Health SCANDAL! Sugar Industry Hid Science Linking Sugar to Heart Disease – Blamed Saturated Fats and Cholesterol Instead
FDA Prohibits Free Speech on Coconut Oil – Illegal to Call it “Healthy”
After the McGovern Report condemned saturated fats as “bad” and causing high cholesterol levels leading to heart disease, the FDA enacted rules for nutritional labeling and a recommended daily limit to consuming saturated fats.
If any product contains more than their recommended daily limit, that product cannot be labeled as “healthy.”
Since coconut oil is over 90% saturated, although with medium chain fatty acids that an abundance of scientific studies show are health promoting, it can never be marketed as “healthy.”
I learned this first hand in 2005, just 3 years after starting my company Tropical Traditions, the first company to import and sell a “virgin” coconut oil product from the Philippines.
Consumers from all over the U.S. were discovering just how healthy virgin coconut oil was, and we published their testimonies along with peer-reviewed scientific studies backing the claims (that growing body of research is found here.)
But the FDA issued us a warning letter stating that we were selling “unapproved drugs” since they had not sanctioned or approved any of these claims, in spite of the abundance of testimonials and scientific studies.
Since we did not have the funds to go through the drug approval process, which can cost billions of dollars, and since the FDA has never approved of a natural substance that cannot be patented as a “drug,” we were forced to remove all testimonials and links to the scientific literature from the website where we were selling coconut oil.
This body of research now exists at CoconutOil.com.
This FDA rule is being used by attorneys who specialize in class action lawsuits to sue companies who sell coconut oil and market it as “healthy.”
In 2017 we reported on several of these lawsuits being litigated in California:
Coconut Oil is a Threat to U.S. Subsidized Edible Oils and Big Pharma’s Cholesterol Drugs
Coconut oil is derived from coconuts, and must be imported as it is not produced much in the U.S.
Due to its growth in popularity in recent years, it can be seen as a threat to the edible oil industry and the pharmaceutical industry.
The United States is the world’s largest supplier of polyunsaturated edible oils, derived mainly from corn and soybeans, two very highly subsidized crops. As a result, the U.S. dominates the worldwide edible oil industry with these “vegetable oils.”
The concerted attack against saturated fats led to the industrial processing of corn and soy into edible oils. These are not traditional oils that have been in the food chain prior to WWII, as expeller-pressed technology was needed to extract oil from these crops.
These vegetable oils need to be chemically processed to remain shelf-stable as a dietary oil, and over 90% of the crops of corn and soy in the U.S. are from GMO seeds.
Dr. Mary Enig’s excellent treatment of the history of the edible oil industry in America is well worth reading:
USDA dietary advice promotes polyunsaturated oils as “heart healthy,” in spite of strong evidence to the contrary.
In 2013 a report published in the British Medical Journal looked at resurrected data from a 1960s study, the Sydney Diet Heart Study, which supports a completely different conclusion about the effects of polyunsaturated oils on heart disease.
Not only does the evidence not support the claim that polyunsaturated fats prevent heart disease, it shows that just the opposite is true! The conclusion from the abstract:
Advice to substitute polyunsaturated fats for saturated fats is a key component of worldwide dietary guidelines for coronary heart disease risk reduction.
However, clinical benefits of the most abundant polyunsaturated fatty acid, omega 6 linoleic acid, have not been established. In this cohort, substituting dietary linoleic acid in place of saturated fats increased the rates of death from all causes, coronary heart disease, and cardiovascular disease.
An updated meta-analysis of linoleic acid intervention trials showed no evidence of cardiovascular benefit.
These findings could have important implications for worldwide dietary advice to substitute omega 6 linoleic acid, or polyunsaturated fats in general, for saturated fats. (Italics added.)
Resurrected Data From 1960s Shows American Heart Association’s Advice on Dietary Fats has been Wrong
Profitable Cholesterol Drugs
It is a well-known fact that historically, drugs designed to lower cholesterol (statins) have been the most prescribed and most profitable drugs in the history of mankind. It is a $100 billion a year industry.
The cholesterol-lowering drug Lipitor is the best-selling drug of all time, grossing over $140 billion, with no serious close competitors in the history of pharmaceutical drugs.
It wasn’t until after the patent on Lipitor ran out, opening the door for cheaper generics to flood the market, that the FDA finally published warnings on the side effects of statin drugs, which include liver injury, memory loss, muscle damage, and Type 2 diabetes.
One out of every four Americans over the age of 50 is taking a statin drug to lower their cholesterol, so this is a huge market that depends upon the success of the lipid theory of heart disease which condemns saturated fats and cholesterol as bad.
How Many Lives Have Been Destroyed by Bad Nutrition Advice?
The science clearly shows how the “lipid theory of heart disease,” the belief that saturated fats and cholesterol cause heart disease, is false, but that science can never be published or exposed by Big Pharma, Big Food, or the U.S. Government.
To do so would be to admit that such dietary advice, and the cholesterol lowering drugs that have earned them hundreds of BILLIONS of dollars, have been a scam and have led to increased rates of obesity, diabetes, heart disease, and cancer.
These are the leading causes of death today.
The polyunsaturated edible oils consumed by over 90% of Americans today, which are not the edible oils of our ancestors, have replaced the traditional saturated fats that our ancestors consumed, such as butter, beef tallow, lard, and vegetable sources such as the tropical oils, coconut oil and palm oil, as well as other traditional oils that have been part of the food chain for thousands of years, such as olive oil.
Until recently, these recent additions to the human food chain, polyunsaturated oils derived from corn and soybeans, had to go through an industrial processing called “hydrogenation” to make them shelf stable and behave like saturated fats.
This process of hydrogenation was found out to be, years later, toxic, as it produced trans fats, which have now been banned in most countries, and require a warning on U.S. food labels.
In addition to the domination of these toxic vegetable oils, official USDA dietary advice, enforced by the FDA, encouraged a low-fat diet, resulting in the consumption of more carbohydrates, mostly in the form of refined sugar.
The fraudulent studies used to exonerate processed sugar and put the blame for heart disease and other diseases on saturated fat, has now been exposed.
The blood of millions of Americans who followed the advice from this faulty science used by the U.S. government now stains the hands of all those who corrupted the science, and the politicians who enforced it.
Virgin Coconut Oil:
How it has changed people’s lives and how it can change yours!